Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection.

Alimentary pharmacology & therapeutics - 1 Feb 2014

Covolo L, Bibert S, Donato F, Bochud P-Y, Lagging M, Negro F, Fattovich G

Abstract excerpt

BACKGROUND: A novel dinucleotide variant TT/∆G (ss469415590) has been associated with hepatitis C virus clearance. AIM: To assess the role of the ss469415590 variant, compared with the known IL28B polymorphisms (rs8099917, rs12979860 and rs12980275) for predicting virological response to therapy in chronic hepatitis C, and its association with the CXCL10 chemokine serum levels - a surrogate marker of...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemokine CXCL10
Share to Drug Therapy, Combination
Share to Hepatitis C, Chronic
Share to Interferon-alpha
Share to Interferon alpha-2
Share to Multivariate Analysis
Share to Polyethylene Glycols
Share to Ribavirin

Source

Identifiers

PMID: 24308755
DOI: 10.1111/apt.12568

Genes

CXCL10

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection.PMID 24308755Read ↗

IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians.Semantic proximity Read ↗

Correlation of interferon-lambda 4 ss469415590 with the hepatitis C virus treatment response and its comparison with interleukin 28b polymorphisms in predicting a sustained virological response: a meta-analysis.Semantic proximity Read ↗

IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection.Semantic proximity Read ↗

IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients.Semantic proximity Read ↗

Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.Semantic proximity Read ↗

Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.Semantic proximity Read ↗

Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C.Semantic proximity Read ↗

Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis CSemantic proximity Read ↗

Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population.Semantic proximity Read ↗

CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients.Semantic proximity Read ↗

Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.Semantic proximity Read ↗

DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.